- Home
- FRBA vs CMPX Comparison
FRBA vs CMPX Comparison
Compare FRBA & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRBA
- CMPX
- Stock Information
- Founded
- FRBA 2007
- CMPX 2014
- Country
- FRBA United States
- CMPX United States
- Employees
- FRBA N/A
- CMPX N/A
- Industry
- FRBA Major Banks
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- FRBA Finance
- CMPX Health Care
- Exchange
- FRBA Nasdaq
- CMPX Nasdaq
- Market Cap
- FRBA 364.6M
- CMPX 291.8M
- IPO Year
- FRBA N/A
- CMPX N/A
- Fundamental
- Price
- FRBA $16.72
- CMPX $3.28
- Analyst Decision
- FRBA Strong Buy
- CMPX Strong Buy
- Analyst Count
- FRBA 2
- CMPX 8
- Target Price
- FRBA $18.00
- CMPX $13.50
- AVG Volume (30 Days)
- FRBA 49.9K
- CMPX 1.4M
- Earning Date
- FRBA 10-22-2025
- CMPX 08-11-2025
- Dividend Yield
- FRBA 1.44%
- CMPX N/A
- EPS Growth
- FRBA 22.16
- CMPX N/A
- EPS
- FRBA 1.51
- CMPX N/A
- Revenue
- FRBA $131,202,000.00
- CMPX N/A
- Revenue This Year
- FRBA $12.28
- CMPX N/A
- Revenue Next Year
- FRBA $6.37
- CMPX N/A
- P/E Ratio
- FRBA $11.06
- CMPX N/A
- Revenue Growth
- FRBA 14.51
- CMPX N/A
- 52 Week Low
- FRBA $12.74
- CMPX $1.19
- 52 Week High
- FRBA $16.89
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- FRBA 71.09
- CMPX 61.11
- Support Level
- FRBA $16.32
- CMPX $2.66
- Resistance Level
- FRBA $16.78
- CMPX $3.47
- Average True Range (ATR)
- FRBA 0.35
- CMPX 0.24
- MACD
- FRBA 0.12
- CMPX 0.02
- Stochastic Oscillator
- FRBA 92.12
- CMPX 76.54
About FRBA First Bank
First Bank is a full-service commercial bank, with target businesses from individuals, businesses, and governmental entities located in service regions throughout New Jersey and eastern Pennsylvania, with a particular focus between New York City and Philadelphia. The group focuses on traditional deposit and loan products with businesses and individuals living and working in markets as the source of businesses. Its services are Business Banking; Personal banking; Digital Banking; and Lending.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.